0001354488-14-003973.txt : 20140811 0001354488-14-003973.hdr.sgml : 20140811 20140808163703 ACCESSION NUMBER: 0001354488-14-003973 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120806 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20140808 DATE AS OF CHANGE: 20140808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 141027957 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 8-K 1 blfs_8k.htm CURRENT REPORT blfs_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  August 6, 2014

_______________________

BioLife Solutions, Inc.
(Exact name of registrant as specified in its charter)
_______________________
 
Delaware 0-18710 94-3076866
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number)
 
3303 Monte Villa Parkway
Bothell, Washington 98021
(Address of principal executive offices, including zip code)

 (425) 402-1400
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
 
 o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
 o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
 o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.24d-2(b))
     
 o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.23e-4(c))
     
 
 
 
 
 
 
 
Item 5.07                      Submission of Matters to a Vote of Security Holders.
 
On August 6, 2014, BioLife Solutions, Inc. (the “Company”) held its 2014 Annual Meeting of Stockholders (the “Annual Meeting”) at its principal executive office in Bothell, Washington. At the Annual Meeting, the Company’s stockholders approved each of the following proposals set forth in the Company’s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on June 20, 2014:

Proposal 1:

The Company’s stockholders elected the following directors to hold office until the 2015 Annual Meeting:
 
Name
  
Votes For
    
Votes Withheld
    
Broker Non-Votes
  
Michael Rice
     6,704,684       116,417       2,953,159  
Raymond Cohen
     6,722,732       98,369       2,953,159  
Andrew Hinson
     6,802,131       18,970       2,953,159  
Joseph Schick
     6,802,169       18,932       2,953,159  
Rick Stewart
     6,802,212       18,889       2,953,159  
 
Proposal 2:
 
The Company’s stockholders ratified the appointment of Peterson Sullivan LLP as our independent registered public accounting firm for 2014, as set forth below:
 
Votes For
  
Votes Against
  
Abstain
  
Broker Non-Votes
 6,696,633    44,591    22,778    2,953,159
 
 
2
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  BIOLIFE SOLUTIONS, INC.  
       
Dated: August 8, 2014
By:
/s/ Daphne Taylor  
    Daphne Taylor  
    Chief Financial Officer  
       

3